ATI AIRTEST TECHNOLOGIES INC (AAT.CA) Fundamental Analysis & Valuation

TSX-V:AAT • CA00208E3077

Current stock price

0.015 CAD
0 (0%)
Last:

This AAT.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. AAT.CA Profitability Analysis

1.1 Basic Checks

  • AAT had negative earnings in the past year.
  • In the past year AAT has reported a negative cash flow from operations.
AAT.CA Yearly Net Income VS EBIT VS OCF VS FCFAAT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -500K -1M -1.5M -2M -2.5M

1.2 Ratios

Industry RankSector Rank
ROA -15.01%
ROE N/A
ROIC N/A
ROA(3y)-203.4%
ROA(5y)-183.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AAT.CA Yearly ROA, ROE, ROICAAT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300 -400

1.3 Margins

  • AAT's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for AAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.57%
GM growth 5Y-0.06%
AAT.CA Yearly Profit, Operating, Gross MarginsAAT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. AAT.CA Health Analysis

2.1 Basic Checks

  • AAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • AAT has more shares outstanding than it did 1 year ago.
  • AAT has a better debt/assets ratio than last year.
AAT.CA Yearly Shares OutstandingAAT.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
AAT.CA Yearly Total Debt VS Total AssetsAAT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 500K 1M 1.5M 2M

2.2 Solvency

  • Based on the Altman-Z score of -23.12, we must say that AAT is in the distress zone and has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -23.12
ROIC/WACCN/A
WACC5.61%
AAT.CA Yearly LT Debt VS Equity VS FCFAAT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 -2M -4M -6M

2.3 Liquidity

  • AAT has a Current Ratio of 0.26. This is a bad value and indicates that AAT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AAT has a Quick Ratio of 0.26. This is a bad value and indicates that AAT is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.05
AAT.CA Yearly Current Assets VS Current LiabilitesAAT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. AAT.CA Growth Analysis

3.1 Past

  • The earnings per share for AAT have decreased strongly by -21.73% in the last year.
  • Looking at the last year, AAT shows a very negative growth in Revenue. The Revenue has decreased by -10.13% in the last year.
  • AAT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.72% yearly.
EPS 1Y (TTM)-21.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.91%
Revenue 1Y (TTM)-10.13%
Revenue growth 3Y-11.77%
Revenue growth 5Y-7.72%
Sales Q2Q%-29.9%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AAT.CA Yearly Revenue VS EstimatesAAT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M

More info and screens

Find the best growth stocksShow best growing peers

0

4. AAT.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AAT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AAT.CA Price Earnings VS Forward Price EarningsAAT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AAT.CA Per share dataAAT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 -0.04 -0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AAT.CA Dividend Analysis

5.1 Amount

  • AAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

AAT.CA Fundamentals: All Metrics, Ratios and Statistics

ATI AIRTEST TECHNOLOGIES INC

TSX-V:AAT (7/11/2024, 7:00:00 PM)

0.015

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-28
Earnings (Next)08-27
Inst Owners1.73%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap967.68K
Revenue(TTM)2.09M
Net Income(TTM)-194.74K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.03
BVpS-0.07
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.01%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.44%
FCFM N/A
ROA(3y)-203.4%
ROA(5y)-183.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.57%
GM growth 5Y-0.06%
F-Score4
Asset Turnover1.61
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.26
Quick Ratio 0.05
Altman-Z -23.12
F-Score4
WACC5.61%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.91%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.13%
Revenue growth 3Y-11.77%
Revenue growth 5Y-7.72%
Sales Q2Q%-29.9%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.03%
OCF growth 3YN/A
OCF growth 5YN/A

ATI AIRTEST TECHNOLOGIES INC / AAT.CA Fundamental Analysis FAQ

What is the fundamental rating for AAT stock?

ChartMill assigns a fundamental rating of 0 / 10 to AAT.CA.


What is the valuation status of ATI AIRTEST TECHNOLOGIES INC (AAT.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to ATI AIRTEST TECHNOLOGIES INC (AAT.CA). This can be considered as Overvalued.


What is the profitability of AAT stock?

ATI AIRTEST TECHNOLOGIES INC (AAT.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for AAT stock?

The financial health rating of ATI AIRTEST TECHNOLOGIES INC (AAT.CA) is 1 / 10.